---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-22-000353"
form_type: "8-K"
ticker: "AXIM"
cik: "0001514946"
company_name: "AXIM BIOTECHNOLOGIES, INC."
filed_at: "2022-02-16T23:59:59+00:00"
generated_at: "2026-06-27T07:29:33.415008+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AXIM raises $1.825M in new debt; retires $1.11M GS Capital note

## Summary
- Issued two $250K short-term notes (1.5% interest, due March 10, 2022); one repaid on Feb 14.
- Issued seven convertible notes aggregate $1.325M at 3% interest, due 2032; conversion at 70% of avg two lowest closing prices.
- One $25K convertible note was acquired by director Blake N. Schroeder.
- Repaid GS Capital Partners note ($1.11M face) in full; accrued interest $21,876 paid via 173,390 restricted shares.

## SEC filing metadata
- accession: 0001096906-22-000353
- form_type: 8-K
- ticker: AXIM
- cik: 0001514946
- company_name: AXIM BIOTECHNOLOGIES, INC.
- filed_at: 2022-02-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/0001096906-22-000353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim-20220210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-22-000353
- JSON: https://secwatch.observer/filing/0001096906-22-000353.json
- Plain text: https://secwatch.observer/filing/0001096906-22-000353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.